Dr Mary Manuel, MD | |
710 S 8th St, Beaumont, TX 77701-4642 | |
(409) 838-9944 | |
(409) 838-9086 |
Full Name | Dr Mary Manuel |
---|---|
Gender | Female |
Speciality | Pediatrics |
Location | 710 S 8th St, Beaumont, Texas |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1518962364 | NPI | - | NPPES |
00ER04 | Other | TX | BLUE CROSS |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208000000X | Pediatrics | F1135 (Texas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Mary Manuel, MD 710 S 8th St, Beaumont, TX 77701-4642 Ph: (409) 838-9944 | Dr Mary Manuel, MD 710 S 8th St, Beaumont, TX 77701-4642 Ph: (409) 838-9944 |
News Archive
Myriad Genetics, Inc. today announced results from a new study that demonstrated the ability of the myRisk Hereditary Cancer test to detect 105 percent more mutations in cancer causing genes than conventional BRCA testing alone. The Company also presented two key studies in triple negative breast cancer (TNBC) that show the myChoice HRD test accurately predicted response to platinum-based therapy in patients with early-stage TNBC and that the BRACAnalysis molecular diagnostic test significantly predicted response to platinum-based drugs in patients with metastatic TNBC.
Even though a comparative study on the genomic sequences of SARS-CoV, MERS-CoV, and SARS-CoV-2 is available, there is a gap in the research in regards to the comparison between four types of coronaviruses, namely, SARS-CoV, MERS-CoV, BAT-CoV, and SARS-CoV-2. A new study, which deals with the genomic comparison between the sequence of the above-stated four types of coronaviruses, has been published in the Journal of Medical Virology.
Labopharm Inc. today announced that it received notice from the Listings Qualifications Department of The Nasdaq Stock Market (Nasdaq) that the closing bid price of the Corporation's Market Value of Listed Securities (MVLS) was below the minimum requirement of US$50,000,000 for 30 consecutive business days (ended March 28, 2011) and the Corporation was therefore not in compliance with Nasdaq listing rules.
Researchers have identified an enzyme crucial to the malaria parasite's invasion of red blood cells, according to a study in the open-access journal, PLoS Pathogens.
CorTechs Labs, the leading medical software innovator providing solutions for quantitative brain volume analysis is pleased to announce a partnership agreement with Novartis Pharma AG, a global pharmaceutical company.
› Verified 7 days ago
Dr. Ramona Susan Ataya-dakour, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 3070 College St Ste 205, Beaumont, TX 77701 Phone: 409-832-1225 Fax: 409-832-0927 | |
Ariel Scott, Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3330 Fannin St, Beaumont, TX 77701 Phone: 409-832-3304 | |
Melissa Kay Ghorayeb, LVN Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3330 Fannin St, Beaumont, TX 77701 Phone: 409-832-3304 | |
Kelli Brooke Brooks, MSN, NNP-BC Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2830 Calder St, Beaumont, TX 77702 Phone: 409-892-7171 | |
Kamaljit Singh, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2830 Calder St, Beaumont, TX 77702 Phone: 409-550-6777 | |
Dr. Robert B Dundas, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 4450 Highland Ave, Beaumont, TX 77705 Phone: 409-832-1924 Fax: 713-523-4897 | |
Nathan R Roesler, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3127 College St, Beaumont, TX 77701 Phone: 409-899-1433 Fax: 409-981-9086 |